The American Association of Critical-Care Nurses has created an online course that specifically addresses the most serious reported symptoms from COVID-19. The course is available to all nurses, at no charge, to provide vital resources during this challenging time.
A new study published in pre-print by The American Journal of Gastroenterology is the first analysis of gastrointestinal symptoms reported by COVID-19 patients with mild disease rather than those with moderate or critical illness and finds a unique sub-group with low severity disease marked by presence of digestive symptoms, most notably diarrhea. The authors from Union Hospital and Tongji Medical College in Wuhan, China report that among some of the patients included in the study, these digestive symptoms, particularly diarrhea, were the presentation of COVID-19, and were only later, or never, present with respiratory symptoms or fever.
A laboratory at Tulane Medical Center is conducting a new test for COVID-19 that can yield results within four hours.
Cedars-Sinai has joined an international effort to test an experimental antiviral drug as a potential treatment for COVID-19 (coronavirus). The institution expects to enroll its first clinical trial participant this week.
China's control measures during the first 50 days of the COVID-19 epidemic may have delayed the spread of the virus to cities outside of Wuhan by several days and, by interrupting transmission nationwide, prevented more than 700,000 infections across the country, according to an international team of researchers.
Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according to a new editorial published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Using a research assay called VirScan, scientists plan to study how antibodies from people who have had COVID-19 attack the virus that causes it.
A majority (56%) of New York City residents did not think the assistance provided by the federal government for NYC and the state as a whole is sufficient to manage the current coronavirus crisis.
Hazard pay and essential workers are words and phrases that have been more in the news lately due to the COVID-19 pandemic.
Research by the University of Sheffield and Ulster University observed a spike in depression and anxiety after the Prime Minister’s announcement of a lockdown on 23 March
Adults who work long hours are more likely to have hypothyroidism, which is an underactive thyroid, according to study results accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.
IIASA researchers are working to visualize key demographic and socioeconomic information to help inform decisions by health professionals, governments, and policymakers to address the crisis.
• The American Society of Nephrology has launched several initiatives to provide guidance on COVID-19 as it relates to the care of patients with kidney disease.
UC Davis Health physicians and medical staff who treated the first case of community transmission of COVID-19 in the U.S. provide a detailed case study of her condition and the medical steps and challenges they experienced before arriving at a diagnosis and treatment.
Vaccine expert working on developing covid-19 vaccine, sees major differences between Covid-19 and SARS
University of Utah biomedical engineering assistant professor Jessica R. Kramer has received a grant from the National Science Foundation to research how mucus, the slimy substance in human tissue, plays a role in spreading a coronavirus like COVID-19.
In response to the COVID-19 pandemic, Genentech today announced that it will temporarily extend physician payment terms for Lucentis purchases from authorized distributors to 120 days.
Nafamostat mesylate (brand name: Fusan), which is the drug used to treat acute pancreatitis, may effectively block the requisite viral entry process the new coronavirus (SARS-CoV-2) uses to spread and cause disease (COVID-19). The University of Tokyo announced these new findings on March 18, 2020.
UPMC is implementing a staffing and pay protection program, which will ensure that all staff will continue to be paid at their current rate for normally scheduled hours through May 9, 2020 even if they are assigned to alternative work during their regular hours.
As the coronavirus continues to spread across the nation, a number of false conclusions and rumors have spread with it. Three epidemiologists in public health at Washington University in St. Louis separate truth from myth.The following information is from Alexis Duncan and Kim Johnson, associate professors, and Christine Ekenga, an assistant professor, all in the Brown School.
This case series reports a cluster-spreading event in Huai'an (about 435 miles northeast of Wuhan) in Jiangsu Province, China, where a patient with SARS-CoV-2 may have transmitted the virus to eight other healthy individuals through bathing in a public bath center.
To help guide hospital surgery departments through this crisis, the acute surgery division at Atrium Health’s Carolinas Medical Center in Charlotte, N.C., has developed a tiered plan for marshaling limited resources.
A recent study has found that there is no evidence for or against the use of non-steroidal anti-inflammatory drugs such as ibuprofen for patients with COVID-19.
FACULTY Q&ASocial connection is a primary way to cope with mental health difficulties and stress. At a time when much of the population is practicing social distancing due to the spread of COVID-19, the disease caused by a novel coronavirus, losing direct connection with friends, colleagues and extended family can exacerbate existing mental health concerns in an already stressful time.
The Covid-19 pandemic has changed the lives of many throughout the UK, most people are unable to go to work, some have seen their hours cut, some have had their job prospects changed, and for the general population their normal routine is upset, which means their sleeping pattern may be compromised too.
Travel restrictions imposed to curb the spread of COVID-19 are making it more difficult for some heart failure patients who have artificial heart pumps to participate in follow-up care at implantation centers far from their homes. But a new study suggests there may be a viable alternative. According to University of Utah Health researchers, local doctors in rural areas who receive specialized training in managing the devices and who work in conjunction with cardiovascular experts at a major medical center can care for these patients safely and effectively.
A recent Cornell Tech alumnus is applying his health tech skills to a crowdsourcing app that allows users to share their COVID status, to better inform individuals and health authorities.
A multi-site clinical trial, led by the University of Washington School of Medicine in collaboration with New York University Grossman School of Medicine, aims to definitively determine whether hydroxychloroquine can prevent transmission in people exposed to the virus.
Joseph Hanna, an acute care surgeon at Rutgers Robert Wood Johnson Medical School, has turned to his 3-D printing hobby to supply necessary eye and face shields for medical personnel using Ministry of Health–verified prototypes. He is now calling other 3-D printing hobbiests to do the same.
Below please find link(s) to new coronavirus-related content published today in Annals of Internal Medicine. All coronavirus-related content published in Annals of Internal Medicine is free to the public. A complete collection is available at https://annals.org/aim/pages/coronavirus-content.
A team of scientists, including Case Western Reserve University chemistry Professor Blanton Tolbert and his research lab, are conducting the underlying research to develop an antiviral to slow the spread of novel coronavirus that causes COVID-19.
An artificial intelligence tool accurately predicted which patients newly infected with the COVID-19 virus would go on to develop severe respiratory disease, a new study has found.
A public health electronic surveillance tool developed by the Johns Hopkins Applied Physics Laboratory in Laurel, Maryland, is helping to fill gaps by tracking the COVID-19’s spread symptomatically.
Hsueh-Chia Chang, the Bayer Professor of Chemical and Biomolecular Engineering, said technology his lab developed for other uses could easily be extended to apply to testing for the coronavirus.
The Academy of Nutrition and Dietetics has created the COVID-19 Nutrition Resource Center to offer guidance to the public about grocery shopping, healthful eating, recipes, food safety and more.
طوّرت مايو كلينك (Mayo Clinic) فحصًا يستطيع الكشف عن فيروس كورونا المستجد SARS-CoV-2 في العينات السريرية. ويتسبب SARS-CoV-2 في فيروس كورونا COVID-19.
A Mayo Clinic desenvolveu um teste que pode detectar o vírus SARS-CoV-2 em amostras clínicas. O vírus SARS-CoV-2 causa a COVID-19.
New recommendations for best practice for infection prevention and control in healthcare settings, to help stop the spread of COVID-19, have been developed by the University of Adelaide’s JBI, an international research organisation in the Faculty of Health and Medical Sciences.
The Endocrine Society will host its largest-ever online meeting in June to ensure endocrine researchers and clinicians continue to have access to the latest scientific information, despite the COVID-19 pandemic.
When it comes to mitigating the effects of COVID-19 in America, President Trump has made his opinion clear: states need to do more. The problem? Many governors have said they either don’t completely agree with that approach or outright think the opposite. What’s the right approach? Probably somewhere in between, according to Virginia Tech political scientist Karen Hult.
Houston Methodist received FDA approval Saturday to become the first academic medical center in the nation to transfuse donated plasma from a recovered COVID-19 patient into a critically ill patient. This treatment was fast-tracked to the bedside over the weekend as the death toll in the COVID-19 pandemic soared to more than 2,000 people across the United States, with more than 100,000 Americans sick from the virus.
A team of engineers and physicians at the University of California San Diego is working to turn emergency hand-held ventilators into devices that can work autonomously for long periods of time, without human input.
La Jolla Institute for Immunology (LJI) has been awarded a $1.73 million grant by the Bill & Melinda Gates Foundation to establish a Coronavirus Immunotherapy Consortium (CoVIC) as part of the foundation’s global efforts to stem the tide of the current coronavirus outbreak.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right